The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.3. rezultāts no 82.
327. lappuse
... specification to the possibility that interpretation of the claims may be necessary in order to give the patent its true breadth . In a doubtful case this may be helpful in convincing the court that the patent is infringed . A common ...
... specification to the possibility that interpretation of the claims may be necessary in order to give the patent its true breadth . In a doubtful case this may be helpful in convincing the court that the patent is infringed . A common ...
693. lappuse
... specification stated that the compound was highly selective against tumor cells as demonstrated both by in vitro tests and in treatment of certain tumors in rats and mice . The Examiner apparently considered the specification ...
... specification stated that the compound was highly selective against tumor cells as demonstrated both by in vitro tests and in treatment of certain tumors in rats and mice . The Examiner apparently considered the specification ...
699. lappuse
... specification , or the specification does not reveal the unique property on which patentability is based , and with which the affidavit is concerned , the affidavit will normally not be accepted as convincing by the Patent Office . See ...
... specification , or the specification does not reveal the unique property on which patentability is based , and with which the affidavit is concerned , the affidavit will normally not be accepted as convincing by the Patent Office . See ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention